38 results
8-K
EX-99.1
ENTA
Enanta Pharmaceuticals Inc
6 May 24
Results of Operations and Financial Condition
4:05pm
matters across a range of disciplines, including corporate governance, public company reporting, intellectual property, financing, business development … and corporate governance oversight. Prior to joining Enanta, Mr. Kowalsky held legal and operational roles of increasing responsibility at Sigilon
8-K
c7eq d0e9ew3v
23 Aug 21
Departure of Directors or Certain Officers
4:01pm
DEFR14A
dx9p4
28 Jan 21
Revised proxy
4:01pm
8-K
EX-99.1
q83yz elopm
4 Aug 20
Results of Operations and Financial Condition
4:16pm
8-K
djv27
30 Jun 20
Departure of Directors or Certain Officers
4:00pm